Are you getting the best rate from your broker?
Compare your broker's rates now to find out if you can save money

Choose your broker below
Welcome to MutualFunds.com. Please help us personalize your experience.

Select the one that best describes you
Mutualfunds logo

AMREX American Growth Fund Series Two E

  • Fund
  • AMREX
  • Price as of: Nov 15, 2018
  • $4.08
  • + $0.09
  • + 2.26%
  • Category
  • Large Cap Growth Equities

AMREX - Profile

Vitals

  • YTD Return -12.6%
  • 3 Yr Annualized Return -10.1%
  • 5 Yr Annualized Return -4.5%
  • Net Assets $814 K
  • Holdings in Top 10 58.4%

52 WEEK LOW AND HIGH

$4.08
$3.66
$5.21

Expenses

OPERATING RELATED FEES

  • Expense Ratio 15.15%

SALES FEES

  • Front Load 5.75%
  • Deferred Load N/A

BROKERAGE FEES

  • Turnover 8.00%

TRADING FEES

  • Max Redemption Fee N/A

Min Investment

STANDARD (TAXABLE)

$0

IRA

$0

Investment Themes

CATEGORY

Large Cap Growth Equities
  • Fund Type Open End Mutual Fund
  • Investment Style Large Growth

Distributions

  • YTD Total Return -12.6%
  • 3 Yr Annualized Total Return -11.9%
  • 5 Yr Annualized Total Return -5.6%
  • Capital Gain Distribution Frequency N/A
  • Net Income Ratio -14.30%
DIVIDENDS
  • Dividend Yield N/A
  • Dividend Distribution Frequency Annually

Fund Details

  • Legal Name American Growth Fund Series Two
  • Fund Family Name American Growth
  • Inception Date Feb 24, 2011
  • Shares Outstanding N/A
  • Share Class Other
  • Currency USD
  • Domiciled Country United States
  • Manager Timothy Taggart

Fund Description

The Adviser uses a consistent approach to build the fund's security portfolio which is made up primarily of common stocks involved, in at least some way, in the legal cannabis business. It may also invest in securities convertible into common stock in companies involved, in at least some way in the legal cannabis business. These securities may be issued by large companies and also small and mid-sized companies, Micro Cap and REITs. The legal cannabis business does not need to be the sole focus point of a company for Series Two to invest in it nor does it need to account for a majority of its overall revenues.

AMREX - Performance

Return Ranking - Trailing

Period AMREX Return Category Return Low Category Return High Rank in Category (%) Quintile
YTD -12.6% -97.0% 550.6% 88.72% 5
1 Yr 13.0% -52.0% 75.7% 16.40% 1
3 Yr -10.1% * -15.1% 30.2% 98.60% 5
5 Yr -4.5% * -4.5% 17.8% 99.56% 5
10 Yr N/A * 3.4% 19.3% N/A N/A

* Annualized


Return Ranking - Calendar

Period AMREX Return Category Return Low Category Return High Rank in Category (%) Quintile
2017 -5.7% -52.0% 104.4% 88.18% 5
2016 -56.6% -56.6% 121.2% 94.95% 5
2015 -0.8% -41.2% 42.9% 33.00% 2
2014 4.3% -30.1% 45.5% 35.29% 2
2013 19.8% -13.0% 56.4% 71.92% 4

Total Return Ranking - Trailing

Period AMREX Return Category Return Low Category Return High Rank in Category (%) Quintile
YTD -12.6% -100.0% 550.6% 89.21% 5
1 Yr 6.5% -71.3% 2606.2% 56.43% 3
3 Yr -11.9% * -21.9% 43.7% 99.37% 5
5 Yr -5.6% * -5.6% 17.8% 99.56% 5
10 Yr N/A * 3.2% 19.3% N/A N/A

* Annualized


Total Return Ranking - Calendar

Period AMREX Return Category Return Low Category Return High Rank in Category (%) Quintile
2017 -5.7% -43.6% 104.4% 89.51% 5
2016 -56.6% -56.6% 126.1% 95.77% 5
2015 -0.8% -41.2% 382.6% 81.14% 5
2014 4.3% -10.0% 615.0% 91.76% 5
2013 19.8% -100.0% 357.8% 92.92% 5

NAV & Total Return History

AMREX - Holdings

Filings data as of: Jul 31, 2018

Concentration Analysis

AMREX Category Low Category High AMREX % Rank Quintile
Net Assets 814 K 373 K 180 B 36.57% 5
Number of Holdings 38 1 2010 11.95% 5
Net Assets in Top 10 447 K 0 61 B 36.12% 5
Weighting of Top 10 58.4% 0.0% 150.9% 2.51% 1

Top 10 Holdings

  1. The Scotts Miracle Gro Co A 6.54%
  2. Merck & Co Inc 5.51%
  3. Microsoft Corp 7.07%
  4. Cara Therapeutics Inc 5.31%
  5. Abbott Laboratories 6.34%
  6. Gw Pharmaceuticals Plc 9.18%
  7. AbbVie Inc 5.07%
  8. KushCo Holdings Inc 4.54%
  9. Vestas Wind Systems A/S 4.27%
  10. CV Sciences Inc 4.59%

Asset Allocation

Weighting Category Low Category High AMREX % Rank Quintile
Stocks
91.23% 0.00% 105.74% 22.24% 5
Other
8.77% -8.87% 24.55% 0.19% 1
Preferred Stocks
0.00% 0.00% 10.87% 4.11% 5
Convertible Bonds
0.00% 0.00% 3.20% 1.29% 5
Cash
0.00% -22.91% 100.00% 21.47% 5
Bonds
0.00% 0.00% 75.79% 3.28% 5

Stock Sector Breakdown

Weighting Category Low Category High AMREX % Rank Quintile
Healthcare
38.79% -1.03% 99.57% 0.19% 1
Consumer Cyclical
9.20% -2.22% 34.73% 27.57% 5
Technology
9.14% -1.29% 56.28% 32.13% 5
Basic Materials
7.10% -1.65% 12.41% 1.03% 1
Consumer Defense
5.08% -1.43% 20.13% 14.46% 3
Real Estate
4.23% -0.04% 11.06% 1.74% 1
Industrials
4.23% -0.37% 25.62% 27.44% 5
Utilities
0.00% -0.18% 13.18% 9.64% 5
Financial Services
0.00% -2.38% 37.88% 31.56% 5
Energy
0.00% -1.24% 16.17% 22.17% 5
Communication Services
0.00% 0.00% 13.72% 18.77% 5

Stock Geographic Breakdown

Weighting Category Low Category High AMREX % Rank Quintile
US
82.49% 0.00% 102.94% 26.61% 5
Non US
8.74% 0.00% 91.47% 6.75% 1

AMREX - Expenses

Operational Fees

AMREX Fees (% of AUM) Category Low Category High Rank in Category (%) Quintile
Expense Ratio 15.15% 0.00% 37.77% 0.51% 5
Management Fee 1.00% 0.00% 1.44% 0.71% 5
12b-1 Fee 0.30% 0.00% 1.00% 1.13% 3
Administrative Fee N/A 0.00% 1.01% N/A N/A

Sales Fees

AMREX Fees (% of AUM) Category Low Category High AMREX Rank Quintile
Front Load 5.75% 1.50% 8.50% 1.19% 5
Deferred Load N/A 1.00% 5.50% N/A N/A

Trading Fees

AMREX Fees (% of AUM) Category Low Category High AMREX Rank Quintile
Max Redemption Fee N/A 0.05% 5.00% N/A N/A

Turnover Related Fees

Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.

AMREX Fees (% of AUM) Category Low Category High AMREX Rank Quintile
Turnover 8.00% 0.00% 610.00% 13.96% 1

AMREX - Distributions

Dividend Yield Analysis

AMREX Category Low Category High AMREX % Rank Quintile
Dividend Yield N/A 0.00% 11.75% N/A N/A

Dividend Distribution Analysis

AMREX Category Low Category High Category Mode
Dividend Distribution Frequency Annually Annually Monthly Annually

Net Income Ratio Analysis

AMREX Category Low Category High AMREX % Rank Quintile
Net Income Ratio -14.30% -14.30% 3.70% 20.66% 5

Capital Gain Distribution Analysis

AMREX Category Low Category High Capital Mode
Capital Gain Distribution Frequency N/A Annually Daily Annually

AMREX - Managers

Timothy Taggart

Manager

Start Date

Apr 30, 2011

Tenure

7.51

Tenure Rank

7.2%

Timothy Taggart has been a member of the Investment Committee since September of 2010 and is the President of World Capital Brokerage, Inc. For the years prior to that Mr. Taggart served on the Board of Directors for IRC, as Treasurer and Chief Compliance officer as well as on the Board of Directors for WCB as President and Chief Compliance Office.


Robert Fleck

Manager

Start Date

Apr 30, 2011

Tenure

7.51

Tenure Rank

7.2%

Robert Fleck, employee of Investment Research Corporation and Investment Committee member since September 2010. For the years prior to that Mr. Fleck served as President and CEO of World Capital Advisors, LLC., a registered Investment Advisor.


Tenure Analysis

Category Low

0.0

Category High

50.9

Category Average

7.86

Category Mode

0.5